BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
X-WR-TIMEZONE:America/New_York
BEGIN:VEVENT
LOCATION:
SUMMARY:What's New in the World of Antibiotic Stewardship? Part Two
DESCRIPTION:About this Webinar Training\n\nCost: Free\nDate: Thursday\, 
 August 25\, 2022\; 1-2pm ET\nWhat's New in the World of 
 Antibiotic Stewardship? Part Two - Impacts of COVID and Use 
 of TelehealthDr. Sharon Tsay\, Medical Officer at the Centers 
 for Disease Control and Prevention\, will discuss current 
 research and findings in the field of antibiotic 
 stewardship. She will talk specifically about how the 
 COVID-19 pandemic and recent telehealth trends may be 
 impacting antibiotic prescribing.\nWhat You Will Learn\n\nAt 
 the conclusion of the webinar\, learners will be able 
 to:\nUnderstand the impact of the COVID-19 pandemic and 
 recent telehealth trends on antibiotic prescribing.Discuss 
 researcher/expert studies and results regarding antibiotic 
 stewardship. \nWho Should Attend\n\nConsultantsFederal and 
 state government agenciesHealth care decision makersHealth 
 care professionalsHealth centers/health practicesHealth 
 plansHealth systemsHospitalsPopulation health 
 organizationsFaculty\n\nSharon Tsay\, MDDr. Sharon Tsay is a 
 Medical Officer in the Office of Antibiotic Stewardship in 
 the Division of Healthcare Quality Promotion at the Centers 
 for Disease Control and Prevention. In this position\, she 
 works with colleagues at CDC and with external partners\, 
 including public health departments and health systems\, to 
 increase the knowledge of appropriate antibiotic prescribing 
 and successful stewardship interventions.\nPrior to her 
 current position\, Dr. Tsay completed CDC’s Epidemic 
 Intelligence Service fellowship in the Mycotic Diseases 
 Branch\, where she led multi-state outbreaks of fungal 
 disease. Before she joined the CDC\, Dr. Tsay completed 
 infectious diseases fellowship training at the Hospital of 
 the University of Pennsylvania\, and completed her residency 
 in internal medicine at Columbia-New York Presbyterian 
 Hospital.\nDr. Tsay continues to practice clinically as an 
 inpatient infectious diseases consultant at Piedmont 
 Healthcare in Atlanta.\n \nModerator: Sepheen Byron\, DRPH\, 
 MHSSepheen Byron is Assistant Vice President\, Performance 
 Measurement\, at the National Committee for Quality Assurance 
 (NCQA). She oversees measure development and use of HEDIS 
 and other national evaluation programs and has developed 
 measures used by NCQA for Accreditation\, benchmarking and 
 ratings. She also led measure development for Medicaid and 
 CHIP enrollees as part of NCQA’s AHRQ-CMS Pediatric 
 Quality Measures Program Center of Excellence. Ms. Byron is 
 the subject matter expert for measures in the area of 
 antibiotic stewardship\, and recently led a project to 
 broaden HEDIS antibiotic measures to additional 
 populations.\nPrior to NCQA\, Ms. Byron was an Analyst in the 
 Center for Outcomes and Evidence at the Agency for 
 Healthcare Research and Quality\, where she assessed the 
 effectiveness of health services.\nMs. Byron has a BA from 
 the University of Virginia\, an MHS from the Johns Hopkins 
 University Bloomberg School of Public Health\, and a DrPH 
 from the Gillings School of Global Public Health\, University 
 of North Carolina at Chapel Hill.\nContinuing 
 Education\n\nIn support of improving patient care\, the 
 National Committee for Quality Assurance is jointly 
 accredited by the Accreditation Council for Continuing 
 Medical Education (ACCME)\, the Accreditation Council for 
 Pharmacy Education (ACPE)\, the American Nurses Credentialing 
 Center (ANCC) to provide Interprofessional Continuing 
 Education for the healthcare team. \nThis activity was 
 planned by and for the healthcare team\, and learners will 
 receive 1.0 Interprofessional Continuing Education (IPCE) 
 credit for learning and change.\nThis educational activity 
 is approved for a maximum of 1.0 AMA PRA Category 1 
 Credit™\, and ACPE. \nThis educational activity is 
 approved for 1.0 nursing contact hours.*\nThe assigned 
 universal program number: JA0004597-0000-22-021-L04-P. Upon 
 successful completion of this program (attending the full 
 session and completing a program evaluation)\, participants 
 will access CPE Monitor on the ACPE website to locate and 
 track their CPE statement of credit.\nThis live course 
 grants 1.0 Continuing Education Unit (CEU) points for PCMH 
 Certified Content Experts.  \n* Please note – You must 
 attend the entire program to be eligible for total number of 
 contact hours.\nNABP Credit Reporting If you are a 
 pharmacist completing a course offering CPE credits\, please 
 notify NCQA through ncqa.org within 14 calendar days that 
 you have completed a CPE course. You must provide the title 
 of the course\, your NABP identification number and your DOB 
 (month/date) within the notification to NCQA. We also 
 recommend you update your education.ncqa.org profile with 
 your NABP identification number.  \nDisclosure of Relevant 
 Financial RelationshipsThe National Committee for Quality 
 Assurance (NCQA) endorses the Standards of the Accreditation 
 Council for Continuing Medical Education which specify that 
 sponsors of continuing medical education activities and 
 presenters at and planners for these activities disclose any 
 relevant financial relationships either party might have 
 with commercial companies whose products or services are 
 discussed in educational presentations.\nFor sponsors\, 
 relevant financial relationships include large research 
 grants\, institutional agreements for joint initiatives\, 
 substantial gifts\, or other relationships that benefit the 
 institution.  For presenters or planning committee members\, 
 relevant financial relationships include the receipt of 
 research grants from a commercial company\, consultancies\, 
 honoraria\, travel\, or other benefits\, or having a 
 self-managed equity interest in a company\; or having an 
 immediate family member or partner with such a 
 relationship.\nDisclosure of a relationship is not intended 
 to suggest or condone bias in any presentation but is made 
 to provide participants with information that might be of 
 potential importance to their evaluation of a 
 presentation.\nRelevant financial relationships exist with 
 the following companies/organizations:\nFaculty:\nSharon 
 Tsay : None\nAdditional Planning Committee Members:\nCrissy 
 Crittenden: None\nNancy McGee: None\nSepheen Byron: Dr. 
 Byron received funding from the Centers for Disease Control 
 and Prevention (contract no. 75D30120C08243) to develop the 
 measure related to antibiotic utilization.\nThis program was 
 developed in part by NCQA staff.\nAcknowledgement\nSupport 
 for this project was provided by The Pew Charitable 
 Trusts.\nDisclaimer\n“The views expressed are those of the 
 author(s) and do not necessarily reflect the views of The 
 Pew Charitable Trusts”.\n
DTSTART:20220825T130000
DTEND:20220825T140000
URL;VALUE=URI:
DTSTAMP:20260414T210845
UID:69dee51d1a345
END:VEVENT
END:VCALENDAR